Dihydroxyacetone reductase
RxNorm 25984
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 25984 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Dihydroxyacetone reductase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
Dihydroxyacetone reductase
(Atom ID: 419783)
PT
Designated preferred name (PT):
Glycerol 2-dehydrogenase (NADP^+^)
(Atom ID: 3800279)
SY
Synonym (SY):
Glycerol 2-dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^)
(Atom ID: 5939627)
FN